Hot Features
THX Pharma Société Anonyme, a biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system disorders. It is involved in the development of Batten-1, an initial drug candidate currently under Phase ½ clinical study for Batten disease. The compan... THX Pharma Société Anonyme, a biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system disorders. It is involved in the development of Batten-1, an initial drug candidate currently under Phase ½ clinical study for Batten disease. The company was formerly known as Theranexus Société Anonyme and change its name to THX Pharma Société Anonyme in September 2025. The company was founded in 2013 and is headquartered in Lyon, France. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.075 | -2.19298245614 | 3.42 | 4.1 | 3.22 | 431951 | 3.83922566 | DE |
| 4 | -0.255 | -7.08333333333 | 3.6 | 4.1 | 3.04 | 169539 | 3.63508098 | DE |
| 12 | 0.435 | 14.9484536082 | 2.91 | 4.1 | 2.86 | 117811 | 3.5155276 | DE |
| 26 | 1.325 | 65.5940594059 | 2.02 | 5.1 | 1.83 | 165891 | 3.33079017 | DE |
| 52 | 2.575 | 334.415584416 | 0.77 | 5.1 | 0.77 | 154193 | 2.77604844 | DE |
| 156 | 1.395 | 71.5384615385 | 1.95 | 5.1 | 0.2605 | 72142 | 2.11151834 | DE |
| 260 | -7.735 | -69.8104693141 | 11.08 | 11.64 | 0.2605 | 53509 | 2.52479515 | DE |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.